A new range of five instruments for ultra-low-volume liquid dispensing for microarray and microfluidics applications, Mercury, has been introduced by Arrayjet.
Arrayjet, a provider of inkjet liquid-handling solutions, launched Mercury, a new core range of five instruments for ultra-low-volume liquid dispensing, in April 2022. According to the company, these new print dispensers offer high functionality and reliability as well as optimal speed and precision. The company offers them in a range of output capacities from 25 to 1000 slides. The instruments can be used for a wide range of microarray and microfluidics applications in pharmaceutical workflows as well as for diagnostic and life science applications.
This range of instruments has been designed to be compact and to have tight environmental controls for printing consistency. The new design is intended to have an easy set-up as well as be user-friendly and simple to maintain. The instruments incorporate a new printhead range that offers faster and more accurate printing of a larger range of volumes and spot sizes.
In addition, advanced capabilities can be custom-tailored or chosen from six application-specific packages comprising printing, scanning, reagents, and substrates, which enable users to access the most relevant functionalities. Furthermore, Mercury is upgradeable and scalable to meet growing manufacturing or research requirements and is fully compatible with future developments from Arrayjet, according to the company in an April 4, 2022 press release.
Arrayjet’s high-speed microarray printers use patented, non-contact inkjet technology for printing multiplex array-based assays onto slides, point-of-care devices, biochips, and microplates. The technology is versatile and can print any biological sample onto any substrate. The Mercury range offers cost-effective, higher-throughput arraying with in-line quality control and requires minimal manual input, according to the company in its press release.
“With the launch of Mercury instruments, our offering is stronger than ever. The new range comprises the fastest and highest throughput microarrayers on the market; helping our customers to reduce costs, save time, and minimize reagent use,” said Iain McWilliam, CEO of Arrayjet, in the press release. “This range incorporates our multidisciplinary team’s assay development expertise and innovation, alongside valued customer feedback, showcasing Arrayjet’s continued dedication to advancing microarray printing.”
Source: Arrayjet
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.